Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000653479 | SCV000775358 | uncertain significance | Pancreatic adenocarcinoma | 2017-10-15 | criteria provided, single submitter | clinical testing | Nucleotide substitutions within the consensus splice site are relatively common causes of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site, but this prediction has not been confirmed by published transcriptional studies. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant has not been reported in the literature in individuals with PALLD-related disease. This variant is not present in population databases (ExAC no frequency). This sequence change affects codon 213 of the PALLD mRNA. It is a 'silent' change, meaning that it does not change the encoded amino acid sequence of the PALLD protein. This variant also falls at the last nucleotide of exon 3 of the PALLD coding sequence, which is part of the consensus splice site for this exon. |